GW&K Investment Management’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-345
Closed -$6K 938
2023
Q4
$6K Hold
345
﹤0.01% 805
2023
Q3
$6K Hold
345
﹤0.01% 757
2023
Q2
$4K Hold
345
﹤0.01% 805
2023
Q1
$4K Hold
345
﹤0.01% 424
2022
Q4
$5K Hold
345
﹤0.01% 393
2022
Q3
$3K Hold
345
﹤0.01% 389
2022
Q2
$4K Hold
345
﹤0.01% 638
2022
Q1
$7K Sell
345
-1,705
-83% -$43.4K ﹤0.01% 476
2021
Q4
$72K Sell
2,050
-185
-8% -$6.01K ﹤0.01% 354
2021
Q3
$82K Sell
2,235
-90
-4% -$3.54K ﹤0.01% 350
2021
Q2
$91K Hold
2,325
﹤0.01% 346
2021
Q1
$66K Buy
2,325
+10
+0.4% +$319 ﹤0.01% 350
2020
Q4
$74K Buy
2,315
+145
+7% +$4.46K ﹤0.01% 342
2020
Q3
$70K Buy
2,170
+225
+12% +$7.01K ﹤0.01% 332
2020
Q2
$54K Buy
1,945
+460
+31% +$9.98K ﹤0.01% 337
2020
Q1
$27K Buy
1,485
+75
+5% +$1.81K ﹤0.01% 341
2019
Q4
$35K Buy
1,410
+135
+11% +$2.96K ﹤0.01% 351
2019
Q3
$23K Buy
+1,275
New +$26.6K ﹤0.01% 347

Other funds holding HCM

GW&K Investment Management's HCM Position: Q1 2024 in Review

GW&K Investment Management sold out of HUTCHMED (HCM) in Q1 2024, closing a stake of 345 shares — an estimated $6K sold.

GW&K Investment Management first reported a position in HCM in Q3 2019 and held it in 18 quarters. The position peaked at $91K in Q2 2021. 71 funds tracked by Wall St. Rank hold HCM as of Q1 2024.

  • GW&K Investment Management reported no remaining HUTCHMED position as of Q1 2024 after selling out during the quarter.
  • GW&K Investment Management sold 345 HUTCHMED shares in Q1 2024, an estimated $6K.
  • GW&K Investment Management first reported a position in HUTCHMED in Q3 2019 and held it in 18 quarters.
  • GW&K Investment Management's HUTCHMED position peaked at $91K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2024.

Based on GW&K Investment Management's 13F filing for Q1 2024, filed 8 May 2024.